Italia markets closed

TEVA Jul 2024 17.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,63000,0000 (0,00%)
In data: 10:29AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,6300
Aperto0,7300
Denaro0,7300
Domanda1,1000
Prezzo d'esercizio17,00
Scadenza2024-07-05
Min-Max giorno0,6300 - 0,7300
Contratto - Min-MaxN/D
Volume4
Open Interest84
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.